Episode Summary
Executive Summary: Peter Atiyah and Dr. Tommy Wood discuss how cognition changes with age, why memory and executive function decline, and how lifestyle, cognitive demand, strength, sleep, and nutrients may preserve brain health. They also examine dementia pathology, especially the limited explanatory power of amyloid, and review concussion/TBI prevention and recovery strategies, including temperature control, creatine, DHA, and choline.
Main Topics: Normal aging and cognitive decline (Priority: 5/5): Wood explains that standardized cognitive performance generally declines with age across most domains, while historical memory is relatively preserved. He distinguishes normal age-related slowing from pathological decline leading to MCI and dementia. What cognition is and why memory feels worse (Priority: 5/5): The conversation breaks cognition into executive function, working memory, processing speed, reaction time, encoding, and retrieval. They emphasize that many complaints reflect retrieval speed, distraction, selective encoding, sleep, and stress rather than true memory loss. Cognitive demand, multitasking, and brain stimulation (Priority: 5/5): Wood argues that true multitasking is mostly impossible; most work-based task switching creates perceived busyness without meaningful cognitive adaptation. He favors focused, skill-based, variable, and socially interactive activities for brain stimulation. Dementia pathology and the amyloid debate (Priority: 5/5): They review Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed neurodegeneration. Wood emphasizes that amyloid and tau correlate poorly with symptoms and may be downstream markers or tombstones of neuronal stress rather than the sole cause. Lifestyle, strength, and modifiable dementia risk (Priority: 5/5): The discussion highlights exercise, sleep, cardiovascular health, education, social interaction, and especially muscle strength as major protective factors. Wood frames strength and muscle as pleiotropic interventions that improve brain health through metabolic, inflammatory, and neurotrophic pathways. Supplements and biomarkers for prevention (Priority: 4/5): Wood discusses homocysteine, omega-3 status, creatine, and choline as practical, low-risk interventions with evidence for cognitive protection or resilience. He argues these are underused despite being cheap and potentially high-yield. Concussion and traumatic brain injury management (Priority: 5/5): The episode closes with a detailed review of concussion/TBI definitions, symptoms, and acute management. Wood emphasizes normothermia, fever prevention, and selective use of creatine, DHA, and choline, while being skeptical of routine hypothermia or hyperbaric oxygen in the acute phase.
Key Arguments: Age-related cognitive decline is real and broadly linear across most cognitive domains, but it is not the same as dementia. Memory complaints often reflect retrieval speed, selective encoding, sleep quality, stress, and distraction rather than loss of stored information. Humans generally do not multitask well; task switching imposes a cognitive cost and often produces busywork rather than adaptation. Cognitive improvement is most likely when activities are complex, variable, interactive, and near the edge of current ability, such as dancing, open-skill sports, or structured brain training. Alzheimer’s pathology is not well explained by amyloid alone; amyloid and tau correlate poorly with symptoms, and may be downstream markers of neuronal stress or lysosomal failure. Late-life dementia risk is strongly shaped by modifiable factors such as physical activity, cardiovascular health, sleep, education, hearing, and nutrient status. Muscle strength is a major predictor of lower dementia incidence and mortality, likely through neuromuscular stimulation, glucose disposal, myokines, and anti-inflammatory effects. Homocysteine reduction with B vitamins and adequate omega-3 status may meaningfully slow cognitive decline and brain atrophy, especially when homocysteine is elevated. Creatine and DHA may improve resilience to concussion and other brain injuries by supporting energy buffering and neuronal membrane integrity. Acute concussion care should prioritize normothermia and fever prevention; routine aggressive cooling or hyperbaric oxygen lacks strong evidence in humans.
Data Points: Age-related cognitive change: Standardized cognitive function decreases with increasing age across most domains - Described as a general population trend, with historical memory relatively preserved Memory preservation: Historical memory is the main cognitive domain that is relatively spared - Attributed to how older memories are consolidated and distributed across cortex Retirement and decline: Earlier retirement is associated with earlier cognitive decline - Used to support the idea that ongoing cognitive demand is protective Population preventability of dementia: 40% - Lancet Commission estimate of dementia preventability based on modifiable risk factors Homocysteine threshold: Above 11 and especially above 13 - Wood cited these as levels associated with elevated risk of cognitive decline Omega-3 / homocysteine interaction: 1 to 2 grams/day DHA - Discussed as a practical supplementation range in the context of cognitive protection Strength and dementia risk: ~70% reduction - Top 10% vs bottom 10% strength associated with lower incidence and mortality from all-cause dementia Task-switching cost: ~20 seconds - Approximate time needed to refocus after switching tasks F1 straight-line speed: 200 to 220 miles/hour - Used to illustrate the cognitive and physical demands on Formula One drivers Therapeutic hypothermia in neonates: 33.5°C for 3 days - Standard of care for certain neonatal brain injuries Normothermia target after concussion: 36.5°C or below - Wood emphasized maintaining normal temperature and preventing fever after brain injury Cooling window after acute brain injury: Within 6 hours, ideally within 3 hours - Based on animal data for when cooling is most likely to help Creatine loading dose: 0.2 g/kg/day, about 20 g/day for a week - Suggested as a way to raise brain creatine before high-risk periods DHA concussion study doses: 2, 4, or 6 grams DHA - All doses were associated with reduced play-related circulating neurofilament light Hyperbaric oxygen exposure: 2 atmospheres, 1 hour, twice weekly - Described as a common chronic-phase protocol, though evidence remains limited Brain training evidence: Brain HQ - Named as a computer-based training program with some of the best evidence for translational cognitive benefit
Pivotal Quotes: "“Humans in general cannot multitask in the way that you describe it.”" — Dr. Tommy Wood: On task switching, distraction, and why busy work often feels productive without being cognitively useful "“The plaque is the tombstone of a previous neuron that failed its ability to process protein.”" — Dr. Tommy Wood: On the interpretation of amyloid plaques in Alzheimer’s disease and the possibility that they are downstream markers "“If you can decrease core temperature by three to four degrees Celsius for 24 hours to 72 hours after the injury, you get a significant reduction in brain injury.”" — Dr. Tommy Wood: On why hypothermia is powerful in animal models and neonatal brain injury, but not proven for routine human concussion care
Implications: Listeners should think of brain health as a systems problem: preserve demand, strength, sleep, vascular/metabolic health, and key nutrients early and continuously. For clinicians, the episode argues for more aggressive prevention and a broader toolkit beyond drugs alone.
About Peter Attia Drive
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.